- NEWS
- Correction 07 July 2021
- Correction 08 July 2021
Mounting evidence suggests Sputnik COVID vaccine is safe and effective
Access options
Subscribe to this journal
Receive 51 print issues and online access
204,58 € per year
only 4,01 € per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 595, 339-340 (2021)
doi: https://doi.org/10.1038/d41586-021-01813-2
Updates & Corrections
-
Correction 07 July 2021: An earlier version of this story stated incorrectly that an analysis of 2.8 million doses that reported no deaths took place in Brazil. In fact, it was in Argentina. The text has been updated.
-
Correction 08 July 2021: An earlier version of this story used the figure for the number of adults randomized to the two doses of placebo in the phase III trial, instead of the figure for the number of adults who actually received two doses of placebo in that trial. That figure has been updated.
References
Logunov, D. Y. et al. Lancet 397, 671–681 (2021).
Logunov, D. Y. et al. Lancet 396, 887–897 (2020).
Pagotto, V. et al. Preprint at medRxiv https://doi.org/10.1101/2021.02.03.21251071 (2021).
Montalti, M. et al. Preprint at medRxiv https://doi.org/10.1101/2021.05.03.21256509 (2021).
Can Cuba beat COVID with its homegrown vaccines?
Six months of COVID vaccines: what 1.7 billion doses have taught scientists
China’s COVID vaccines are going global — but questions remain
Researchers highlight ‘questionable’ data in Russian coronavirus vaccine trial results